EyePoint Pharmaceuticals logo
EyePoint Pharmaceuticals EYPT
$ 11.27 -3.68%

Квартальный отчет 2024-Q2
добавлен 08.08.2024

report update icon

EyePoint Pharmaceuticals Мультипликаторы 2011-2024 | EYPT

Мультипликаторы по годам EyePoint Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-13.4 -0.9 -6.0 -3.2 -3.5 -2.0 -2.3 -5.6 18.8 -9.3 -7.2 -2.5 -10.6

P/S

20.6 2.2 9.5 4.2 9.6 35.3 5.6 74.6 4.5 35.8 40.0 17.3 18.4

EPS

-1.8 -2.7 -2.0 -3.5 -5.4 -1.3 -0.5 -0.7 0.2 -0.5 -0.5 -1.2 -0.4

EV (Enterprise Value)

756 млн 81.3 млн 252 млн 172 млн 239 млн 119 млн 30.9 млн 116 млн 109 млн 117 млн 87.4 млн 63.5 млн 88.4 млн

EBITDA per Share

-1.92 -2.66 -1.91 -2.71 -4.35 -5.44 -5.03 -6.6 2.49 -4.61 -4.79 -3.92 -3.41

EV/EBITDA

-4.5 -4.2 -4.9 -3.3 -1.4 -5.1 13.7 -8.6 -7.1 -6.9 -11.8

PEG

0.88 0.11 0.29 -0.09 0.0 0.02 -0.1 0.01 0.13 -1.61 -0.13 0.01 0.06

P/B

3.6 1.0 1.9 7.8 23.5 8.9 3.2 5.8 5.1 8.3 11.1 4.5 2.4

P/CF

505.6 -1.4 -7.0 -9.7 -3.4 -4.7 -2.1 -7.4 11.8 -11.4 -9.7 -6.5 -27.7

ROE %

-26.58 -106.11 -31.68 -244.83 -681.79 -454.96 -138.61 -103.19 27.16 -89.49 -154.55 -182.13 -23.05

ROA %

-19.93 -56.70 -22.18 -49.49 -77.83 -74.19 -98.97 -68.15 19.61 -58.91 -73.24 -120.58 -18.31

ROCE %

-28.19 -103.39 -29.98 -48.54 -77.88 -52.54 -138.76 -82.09 22.13 -66.04 -92.93 -59.60 -23.77

Current Ratio

4.0 2.1 3.3 4.2 3.6 1.8 3.4 5.9 8.9 9.1 3.8 5.0 5.0

DSO

64.7 149.2 137.4 100.2 203.7 43.5 12.2 110.0 8.5 54.3 101.7 100.1 62.0

DIO

- - - 334.5 290.4 - - - - - - - -

DPO

- - - 301.5 569.4 - - - - - - - -

Операционный цикл

64.7 149.2 137.4 434.7 494.2 - - - - - - - -

Финансовый цикл

64.7 149.2 137.4 133.2 -75.3 - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально EyePoint Pharmaceuticals

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.58 - -0.33 -0.61 -0.56 - -0.49 -0.52 -0.56 - -0.58 -0.35 -0.5 - -0.3 -1.04 -1.14 -0.1 -0.15 -0.11 -0.2 -0.12 -0.44 -0.62 -0.44 -0.13 -0.15 -0.13 -0.15 - -0.21 - -0.15 -0.18 -0.17 -0.34 -0.17 -0.14 0.7 -0.14 0.7 -0.13 -0.14 -0.13 -0.14 -0.11 -0.11 -0.11 -0.11 -0.84 -0.12 -0.84 -0.12

EBITDA per Share

- - - - -0.57 - -0.48 -0.51 -0.49 - -0.52 -0.36 -0.44 - -0.14 -0.89 -0.99 -0.08 -0.13 -0.09 -0.15 -0.12 -0.18 -0.18 -0.18 -0.13 -0.15 -0.13 -0.15 - -0.21 - -0.21 -0.17 -0.17 -0.18 -0.17 -0.13 0.71 -0.14 0.71 -0.12 -0.14 -0.13 -0.14 -0.11 -0.11 -0.11 -0.11 -0.81 -0.12 -0.85 -0.12

ROE %

-96.56 -88.54 -102.05 -94.04 -66.84 -38.90 -56.90 -61.40 -57.94 -37.98 -58.48 -60.98 -121.46 -161.40 -286.37 -453.71 -521.89 -681.79 -587.63 -487.81 -441.26 -298.34 -325.91 -304.35 -271.24 -249.69 -191.77 -175.29 -117.37 -100.47 -135.97 -112.19 -147.69 -124.32 -100.99 -17.34 5.98 170.00 154.73 71.39 38.38 -147.31 -138.30 -128.19 -101.68 -72.50 -151.75 -142.85 -170.37 -158.14 -6.89 -46.64 -6.48

ROA %

-38.32 -34.62 -42.97 -43.45 -38.98 -25.51 -35.43 -28.42 -34.02 -22.08 -26.23 -20.45 -28.97 -32.63 -46.89 -64.19 -65.83 -77.83 -78.40 -99.33 -127.62 -143.63 -169.53 -172.04 -158.96 -148.61 -108.23 -92.06 -61.31 -51.93 -73.24 -62.48 -78.29 -70.88 -59.37 5.61 3.66 109.62 102.88 39.64 35.99 -77.41 -72.93 -67.64 -58.68 -48.37 -105.96 -100.66 -125.06 -117.82 -5.63 -37.06 -5.15

ROCE %

-104.00 -91.81 -105.30 -94.23 -67.18 -37.15 -53.66 -56.68 -54.25 -36.23 -46.79 -40.83 -90.71 -132.43 -240.29 -398.52 -460.40 -574.56 -495.94 -363.17 -267.13 -127.27 -156.66 -187.37 -220.02 -250.73 -192.73 -176.16 -118.16 -101.17 -136.85 -113.17 -148.84 -125.59 -102.02 -17.48 6.08 171.86 156.51 72.33 39.09 -148.49 -139.56 -129.47 -102.90 -73.61 -153.59 -144.75 -172.47 -160.23 -7.18 -47.13 -6.76

Current Ratio

3.4 4.0 1.6 1.5 2.0 2.1 2.6 - 3.1 3.3 2.2 2.5 2.6 1.2 1.2 1.2 1.2 1.1 1.1 1.1 1.1 1.9 1.9 1.9 1.9 3.3 3.1 3.5 3.5 4.0 2.4 2.9 2.9 2.5 3.2 3.6 3.6 5.1 5.5 2.9 2.9 2.5 2.7 1.9 1.9 2.9 3.2 3.0 3.0 3.5 5.5 4.9 4.9

DSO

10.5 - 34.3 107.1 153.9 - 95.1 77.3 186.3 - 144.6 138.9 135.7 - 55.0 209.3 126.8 120.1 413.4 143.9 272.0 23.4 117.7 80.0 45.0 28.1 63.8 17.4 54.8 7.0 156.5 7.5 174.8 99.1 116.6 107.9 132.1 2293.4 46.8 90.5 2.1 134.7 130.6 92.0 118.1 147.1 157.2 150.8 163.6 125.9 43.1 122.1 -

DIO

246.8 - - 212.1 - - - - - - - - - - - - - - - 276.3 334.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

677.4 - - 513.5 - - - - - - - - - - - - - - - 541.8 944.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

257.3 - 34.3 319.2 153.9 - 95.1 77.3 186.3 - 144.6 138.9 135.7 - 55.0 209.3 126.8 120.1 413.4 420.2 606.2 23.4 117.7 80.0 45.0 28.1 63.8 17.4 54.8 7.0 156.5 7.5 174.8 99.1 116.6 107.9 132.1 2293.4 46.8 90.5 2.1 134.7 130.6 92.0 118.1 147.1 157.2 150.8 163.6 125.9 43.1 122.1 -

Финансовый цикл

-420.1 - 34.3 -194.3 153.9 - 95.1 77.3 186.3 - 144.6 138.9 135.7 - 55.0 209.3 126.8 120.1 413.4 -121.6 -338.4 23.4 117.7 80.0 45.0 28.1 63.8 17.4 54.8 7.0 156.5 7.5 174.8 99.1 116.6 107.9 132.1 2293.4 46.8 90.5 2.1 134.7 130.6 92.0 118.1 147.1 157.2 150.8 163.6 125.9 43.1 122.1 -

Все данные представлены в валюте USD